If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJourneo Regulatory News (JNEO)

Share Price Information for Journeo (JNEO)

Share Price is delayed by 15 minutes
Get Live Data
475.00    2.50 (0.53%)
Bid:
470.00
Ask:
480.00
Spread: 10.00 (2.128%)
Market Cap: £83.96m
JNEO Live PriceLast checked at - London Stock Exchange

Intraday Journeo Share Chart

Director/PDMR Shareholding

26 Mar 2025 09:54

RNS Number : 3083C
Journeo PLC
26 March 2025
 

26 March 2025

 

Journeo plc

("Journeo" or the "Company")

 

Director /PDMR Shareholding

 

Journeo plc (AIM: JNEO), a leading provider of information systems and technical services to transport operators and local authorities, announces that Nick Lowe, Chief Financial Officer, has purchased 9,700 ordinary shares of 6.5p each in the Company ("Ordinary Shares") at a volume weighted average price of approximately 268 pence per Ordinary Share.

 

Following these purchases, Mr Lowe holds a total beneficial interest in 53,500 Ordinary Shares representing approximately 0.32 per cent. of the Company's issued share capital.

 

The notification below, made in accordance with the UK Market Abuse Regulation, provides further details.

 

For further information please contact:

 

Journeo plc 

Russ Singleton, Chief Executive Officer

Nick Lowe, Chief Financial Officer

 +44 (0) 203 651 9166

 

Cavendish Capital Markets Limited

Nominated Adviser and Broker Katy Birkin / Callum Davidson

+44 (0) 207 220 0500

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nick Lowe

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Journeo plc

b)

LEI

213800TKF7L4IEV9W867

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 6.5 pence each

Identification code

GB00BKP51V79

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volumes(s)

Date

Volume(s)

Price(s)

26 / 03 / 25

7,000

267.79p

26 / 03 / 25

2,000

269.7p

26 / 03 / 25

700

270.0p

d)

Aggregated information

Aggregated volume

9,700

Price

Volume weighted average price of 268p

e)

Date of the transaction

26 March 2025

f)

Place of the transaction

AIMX

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKZGZFLVDGKZG
Date   Source Headline
26th Jul 20217:00 amRNSTender Award and Trading Update
14th Jul 20217:00 amRNSPreferred Supplier
12th Jul 20217:00 amRNSPurchase Orders
21st Apr 202112:51 pmRNSResult of AGM
25th Mar 20217:00 amRNSFinal Results
17th Mar 20217:00 amRNSNew Purchase Orders
25th Jan 20217:00 amRNSFramework agreement contract extension
22nd Jan 20217:00 amRNSNew purchase orders
14th Dec 20207:00 amRNSTrading Update and Loan Note extension
12th Oct 20207:00 amRNSNew purchase order
14th Sep 20207:00 amRNSHalf-year Report
3rd Aug 20207:00 amRNSFramework Contract Renewal
23rd Jul 20207:00 amRNSReceipt of Purchase Orders and Trading Update
29th Apr 20202:31 pmRNSResult of AGM
15th Apr 20203:21 pmRNSHolding(s) in Company
14th Apr 202011:22 amRNSHolding(s) in Company
3rd Apr 202012:15 pmRNSIssue of Equity
2nd Apr 202012:07 pmRNSGrant of Options and Director/PDMR Shareholding
2nd Apr 20207:00 amRNSFinal Results
27th Feb 20207:00 amRNSTransforming Cities Fund Order
27th Jan 20207:00 amRNSPurchase orders received
7th Jan 20204:15 pmRNSDirector/PDMR Shareholding
3rd Jan 20209:59 amRNSHolding(s) in Company
17th Dec 20193:07 pmRNSHolding(s) in Company
17th Dec 20199:42 amRNSHolding(s) in Company
17th Dec 20198:58 amRNSHolding(s) in Company
10th Dec 20194:39 pmRNSDirector/PDMR Shareholding
10th Dec 201912:39 pmRNSResult of Equity Issue
10th Dec 20197:01 amRNSIssue of Equity
10th Dec 20197:00 amRNSTrading Statement
2nd Dec 201911:33 amRNSResult of Meeting
13th Nov 20197:00 amRNSProposed Share Reorganisation, Change of Name, GM
28th Oct 20197:00 amRNSChange of Adviser
8th Oct 20197:00 amRNSNotification of Contract Award Recommendation
16th Sep 20197:00 amRNSInterim Results
2nd Sep 20197:00 amRNSContract Award
24th Jul 20192:00 pmRNSHolding(s) in Company
22nd Jul 20197:00 amRNSNew Contract Awards with WMCA
22nd May 20197:00 amRNS3-year contract renewal with Arriva UK Bus
24th Apr 20195:20 pmRNSResult of AGM
26th Mar 20197:00 amRNSFinal Results
24th Dec 20187:00 amRNSTrading update and extension of loan note
2nd Nov 20187:00 amRNSExclusive distribution agreement
3rd Sep 20187:00 amRNSInterim Results
21st May 201812:02 pmRNSHolding(s) in Company
25th Apr 201810:47 amRNSResult of AGM & Corporate Presentation
28th Mar 20187:00 amRNSFinal Results
19th Mar 201812:26 pmRNSHolding(s) in Company
16th Mar 20181:30 pmRNSRe: Contract
15th Feb 20187:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.